Primero fué SANDOZ, ahora ROCHE: Los suizos estan "salidos"... de los organismos gremiales internacionales.

Primero fué Daniel Vasella el que dió el "portazo" y dejó a SANDOZ fuera de la IFPMA. No los gustaban los controles que imponía la Asociación que, según su entender, "limitaban" la operatividad de esa compañía "bipolar"

"Sandoz is no longer a member of IFPMA and does not have to comply with its obligations."
dijeron.

Ahora es ROCHE... En el 2008 la ABPI le sacó "tarjeta roja" y fué suspendida "su militancia" por las malas prácticas con XENICAL.

Seis meses después, transcurrido el tiempo "pertinente", autorizaron su regreso.

Ahora dicen que no les interesa, que seguiran fuera:

30 June 2009
In a shock move Swiss drugmaker Roche has decided not to renew its membership of the Association of the British Pharmaceutical Industry, putting a question mark over the viability of self-regulation in the UK.

In the UK, the Medicines and Healthcare products Regulatory Agency possesses the legal power to take pharmaceutical groups to court for any wrongdoing, but generally it is the ABPI’s Precription Medicines Code of Practice Authority that deals out penalties to its member companies for bad behaviour.

Roche has been on the receiving end of ABPI sanctions before, after its membership was suspended for six months until February this year in connection with “serious breaches” of the Association’s Code of Practice, relating to the inappropriate sale of large quantities of its weight-loss drug Xenical (orlistat) to an operator of private diet clinics.

Now the company says that its time away from the ABPI gave it the opportunity to “reflect upon the nature” of its relationship with the trade body and consider mutual needs in the future. “We have concluded that this is something we need to review further and for that reason, we have decided not to re-join the ABPI for the time being [but] will continue to review this situation,” the group said in an e-mailed statement to PharmaTimes UK News.


Más...

Pero la decisión no se limita al abandono de la ABPI sino que tambien consideran cancelar su adhesión a la Pharmaceutical Research and Manufacturers Association (PhRMA):
Hoffman La Roche is severing its ties to Big Pharma.

The venerable drug maker this week plans to drop its membership in the Pharmaceutical Research and Manufacturers Association.

PhRMA, as it is known informally, is the leading trade group for the U.S. pharmaceutical industry.

Más...

En resumen..."no me dejan jugar como quiero...rompo la baraja"